Impact of Morphine withdrawal on genes related to the TLR2 pathway expressed in the Prefrontal Cortex
Bridget Truitt1, Junyi Tao1, Sabita Roy1
1Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Abstract:
Millions of people suffer from opioid use disorder, because of the ongoing opioid epidemic. The aversive symptoms of withdrawal are a leading factor for drug relapses, yet there are limited therapeutic options to minimize or prevent withdrawal symptoms. The mechanism behind opioid withdrawal is still not fully understood, thus preventing the development of new therapeutics. This study is an extension of our previously proposed mechanism of a toll-like receptor 2 (TLR2) mediated withdrawal response as a result of morphine induced microbial change that occurs during morphine withdrawal. Transcriptome analysis of the pre-frontal cortex indicated that there was increased expression of genes related to TLR2 signaling in morphine withdrawal treated animals compared to placebo controls. Antibiotic treatment further altered TLR2 related genes, recovering some of the morphine induced effect and leading to additional suppression of some genes related to the TLR2 pathway. Morphine withdrawal induced gene expression was attenuated in a whole body TLR2 knockout model. These results provide more support that TLR2 plays an integral role in morphine withdrawal mechanisms and could be a potential therapeutic target to minimize opioid withdrawal associated co-morbidities.
Insights
Opioid withdrawal symptoms drive relapse, but mechanisms remain unclear. This study reveals toll-like receptor 2 (TLR2) plays a key role in morphine withdrawal, suggesting it as a potential therapeutic target.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Opioid use disorder (OUD) is a major public health crisis, with withdrawal symptoms contributing significantly to relapse.
- Current therapeutic options for mitigating opioid withdrawal are limited due to an incomplete understanding of underlying mechanisms.
- Previous research suggests a link between morphine-induced microbial changes and withdrawal responses mediated by toll-like receptor 2 (TLR2).
Purpose of the Study:
- To investigate the role of toll-like receptor 2 (TLR2) in the mechanisms of morphine withdrawal.
- To explore TLR2 signaling pathways in the pre-frontal cortex during morphine withdrawal.
- To evaluate the potential of TLR2 as a therapeutic target for managing opioid withdrawal.
Main Methods:
- Transcriptome analysis of the pre-frontal cortex in morphine withdrawal models.
- Assessment of TLR2 pathway gene expression following antibiotic treatment.
- Evaluation of morphine withdrawal effects in a whole-body TLR2 knockout mouse model.
Main Results:
- Increased expression of TLR2 signaling pathway genes was observed in the pre-frontal cortex of animals undergoing morphine withdrawal.
- Antibiotic treatment modulated TLR2-related gene expression, partially reversing morphine-induced effects.
- Morphine withdrawal-induced gene expression changes were significantly attenuated in TLR2 knockout mice.
Conclusions:
- Toll-like receptor 2 (TLR2) is integral to the mechanisms underlying morphine withdrawal.
- Targeting TLR2 may offer a novel therapeutic strategy to alleviate opioid withdrawal symptoms and associated comorbidities.
- Further research into TLR2-mediated pathways could lead to improved treatments for opioid use disorder.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Desensitization and Tachyphylaxis
Drug Abuse and Addiction: Pharmacological Phenomena


